CareDx CareDx Acquires App Developer Transplant Hero CareDx said it plans to add Transplant Hero's app, which supports the needs of transplant patients, to its digital portfolio. CareDx Q1 Revenues up 76 Percent The company reported $67.4 million in total revenues for the quarter and said testing service revenues rose 89 percent year over year. Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection Under the policy, covered tests must provide information about active rejection status or cellular or antibody-mediated rejection status. New Products Posted to GenomeWeb: Qiagen, CareDx, Synthego, More People in the News: New Appointments at CareDx, BioSkryb, Oxford Nanopore, More Mar 17, 2021 CareDx Acquires European Transplant Surveillance Software Firm BFS Molecular Feb 25, 2021 CareDx Expanding Diagnostic Tech Into Cell Transplant Monitoring Premium Feb 24, 2021 CareDx Q4 Revenues Up 64 Percent Jan 27, 2021 Heart Transplant Cell-Free DNA Test Enables Earlier Detection of Acute Rejection Than Biopsy Premium Jan 21, 2021 CareDx Prices $175M Common Stock Offering Jan 11, 2021 CareDx Preliminary Q4 Revenues Up 63 Percent, Beat Estimates Jan 7, 2021 CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients Dec 2, 2020 Judge Denies Natera Motion to Invalidate CareDx, Stanford Patents Nov 19, 2020 CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests Nov 2, 2020 GenomeWeb Index Up 5 Percent in October as Favorable Earnings Reports Bolster Shaky Market Oct 30, 2020 People in the News: New Appointments at CareDx, Qiagen, Inscripta, and More Oct 29, 2020 CareDx Q3 Revenues Up 58 Percent Oct 22, 2020 Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences Oct 7, 2020 CareDx Preliminary Q3 Revenues Up 57 Percent Oct 1, 2020 CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto Sep 11, 2020 People in the News: New Appointments at CareDx, Sherlock Biosciences, DermTech, More Aug 4, 2020 CareDx Q2 Revenues Up 33 Percent Aug 4, 2020 GenomeWeb Index Up 13 Percent in July as Investors Cheer COVID Dx Development Jun 26, 2020 BTIG Initiates Coverage of CareDx With Buy Rating Jun 11, 2020 CareDx Prices $125M Public Stock Offering Load More Breaking News Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.